The NIV + nebulizer group had improvement from baseline values , compared to the control group in the following parameters : FEV ( 1 ) 46.7 0.5 % of predicted vs 29.8 8.9 % of predicted , P = .02 ) , FVC ( 41.2 1.5 % of predicted vs 23.2 7.1 % of predicted , P = .02 ) , peak expiratory flow ( 67.3 38.3 % of predicted vs 26.9 12.1 % of predicted , P = .01 ) , and inspiratory capacity ( 54.9 28.8 % of predicted vs 31.2 9.1 % of predicted , P = .01 ) .
